Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0001438133-24-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-28 | 2024-05-28 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | +820 | 46.0K | +2% | $0 |
| D | 2024-05-28 | 2024-05-28 | TNDM | Sheridan John F | Pres, CEO, Dir | F - Tax | $51.73 | -416 | 45.6K | -0.9% | -$21.5K |
| D | 2024-05-28 | 2024-05-28 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | -820 | 0 | -100% | $0 |
| DM | 2024-05-28 | 2024-05-23 | TNDM | Sheridan John F | Pres, CEO, Dir | A - Grant | $0.00 | +143.6K | 71.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 820 | $0.00 | 45,991 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-28 | F | D | 416 | $51.73 | 45,575 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-05-28 | M | D | 820 | $0.00 | 0 | D | — · — to — | 820 Common Stock | (F6) Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). (F7) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. (F8) RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. |
| 4 | Derivative | Restricted Stock Unit | 2024-05-23 | A | A | 71,787 | $0.00 | 71,787 | D | — · — to — | 71,787 Common Stock | (F2) Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). (F3) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F4) RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. |
| 5 | Derivative | Performance Stock Unit | 2024-05-23 | A | A | 71,787 | $0.00 | 71,787 | D | — · — to — | 71,787 Common Stock | (F2) Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). (F5) Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |